SUPERNUS PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Property, Plant and Equipment, Gross of $29.36 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-03
- 2026-06-30: Property, Plant and Equipment, Gross $29.36M.
- 2026-03-31: Property, Plant and Equipment, Gross $28.80M.
- 2025-12-31: Property, Plant and Equipment, Gross $28.80M.
- 2025-09-30: Property, Plant and Equipment, Gross $30.09M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $29.36M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $28.80M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $28.80M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $30.09M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $30.05M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $29.78M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $29.39M 10-K · filed 2026-03-02 |
| 2024-09-30 | $29.12M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $28.90M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $28.99M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $28.93M 10-K · filed 2025-02-25 |
| 2023-09-30 | $28.60M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $28.49M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $28.30M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $28.22M 10-Q · filed 2023-11-08 |
| 2022-09-30 | $28.81M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $28.52M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $29.70M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $33.41M 10-K · filed 2023-03-09 |
| 2020-09-30 | $31.91M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $31.74M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $31.18M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $29.77M 10-Q · filed 2020-11-06 |
| 2019-09-30 | $22.31M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $15.99M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $15.82M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $15.31M 10-K · filed 2020-02-28 |
| 2018-09-30 | $17.76M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $15.14M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $14.77M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $14.47M 10-K · filed 2019-03-01 |
| 2017-09-30 | $13.71M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $13.29M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $12.74M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $12.44M 10-K · filed 2018-03-01 |
| 2016-09-30 | $12.14M 10-Q · filed 2017-01-20 |
| 2016-06-30 | $11.75M 10-Q/A · filed 2017-01-23 |
| 2016-03-31 | $11.12M 10-Q/A · filed 2017-01-20 |
| 2015-12-31 | $10.84M 10-K · filed 2017-03-16 |
| 2015-09-30 | $9.98M 10-Q/A · filed 2017-01-20 |
| 2015-06-30 | $9.52M 10-Q/A · filed 2017-01-23 |
| 2015-03-31 | $8.93M 10-Q/A · filed 2017-01-20 |
| 2014-12-31 | $8.74M 10-Q/A · filed 2017-01-20 |
| 2014-09-30 | $8.62M 10-Q/A · filed 2017-01-20 |
| 2014-06-30 | $8.53M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $8.41M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $8.14M 10-K · filed 2015-03-12 |
| 2013-09-30 | $7.91M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $7.54M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $6.87M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $6.50M 10-K · filed 2014-03-21 |
| 2012-09-30 | $6.30M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $5.91M 10-Q · filed 2012-08-13 |
| 2011-12-31 | $5.75M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |